CDKN2A and lymphoma: Experiments in cell culture and in mice with drug-sensitive (Eμ-myc/Arf-/-) and drug-resistant (Eμ-myc/p53-/-) lymphoma cell lines were conducted to calibrate and validate a mechanistic mathematical model.